Supplemental material
Leukemia & Lymphoma
Volume 58, 2017 - Issue 11
Original Articles: Clinical
Safety and feasibility of lower antithrombin replacement targets in adult patients with hematological malignancies receiving asparaginase therapy*
Jason N. BarretoDepartment of Pharmacy Services, Mayo Clinic, Rochester, MN, USA; Correspondence[email protected]
http://orcid.org/0000-0003-2146-5766View further author information
http://orcid.org/0000-0003-2146-5766View further author information, , , , , , Dennis A. GastineauDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAhttp://orcid.org/0000-0003-2250-9812View further author information
http://orcid.org/0000-0003-2250-9812View further author information, Aref Al-KaliDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAhttp://orcid.org/0000-0002-0824-3715View further author information
http://orcid.org/0000-0002-0824-3715View further author information, , , William J. HoganDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAhttp://orcid.org/0000-0002-5841-4105View further author information
http://orcid.org/0000-0002-5841-4105View further author information, Mark R. LitzowDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAhttp://orcid.org/0000-0002-9816-6302View further author information
http://orcid.org/0000-0002-9816-6302View further author information & Mrinal M. PatnaikDivision of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USAhttp://orcid.org/0000-0001-6998-662XView further author information
http://orcid.org/0000-0001-6998-662XView further author information show all